A Podcast Discussion on Medical Treatment in R/M-SCCHN in the Year 2025-Standard and Considerations for an Individualized Treatment.

Saved in:
Bibliographic Details
Title: A Podcast Discussion on Medical Treatment in R/M-SCCHN in the Year 2025-Standard and Considerations for an Individualized Treatment.
Authors: Ivanyi P; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. ivanyi.philipp@mh-hannover.de.; Lead Group Head and Neck Cancer, German Working Party of Medical Oncologist (AIO), Berlin, Germany. ivanyi.philipp@mh-hannover.de., Fröhlich T; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.; PRACTIS Clinician Scientist Program, Dean's Office for Academic Career Development, Hannover, Deutschland, Medizinische Hochschule Hannover, Hannover, Germany., Wiegmann JP; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Klinghammer K; Lead Group Head and Neck Cancer, German Working Party of Medical Oncologist (AIO), Berlin, Germany.; Department of Hematology, Oncology and Immunology, Charité Berlin, Berlin, Germany.
Source: Oncology and therapy [Oncol Ther] 2026 Mar; Vol. 14 (1), pp. 27-40. Date of Electronic Publication: 2025 Nov 21.
Publication Type: Editorial
Journal Info: Publisher: Adis Country of Publication: New Zealand NLM ID: 101677510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2366-1089 (Electronic) Linking ISSN: 23661089 NLM ISO Abbreviation: Oncol Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2366-1089
DOI:10.1007/s40487-025-00396-6